ARTHROGEN B.V.

arthrogen-bv-logo

Arthrogen, an Amsterdam based biopharmaceutical company, is developing local gene therapy for inflammatory diseases, using viral mediated gene transfer. The first target indication is in the field of rheumatic diseases.

#SimilarOrganizations #People #Financial #Website #More

ARTHROGEN B.V.

Social Links:

Industry:
Biopharma Biotechnology

Founded:
2005-01-01

Address:
Amsterdam, Noord-Holland, The Netherlands

Country:
The Netherlands

Website Url:
http://www.arthrogen.nl

Total Employee:
11+

Status:
Active

Contact:
+31.20.566.26.48

Email Addresses:
[email protected]

Technology used in webpage:
Domain Not Resolving Mobile Non Scaleable Content Cloudflare Hosting Person Schema Facebook Sharer Gravatar Profiles


Similar Organizations

akashi-therapeutics-logo

Akashi Therapeutics

Akashi Therapeutics is a clinical stage biopharmaceutical company.

jenrin-discovery-logo

Jenrin Discovery

Jenrin Discovery is a biopharmaceutical Company.

Current Employees Featured

robert-jan-lamers_image

Robert Jan Lamers
Robert Jan Lamers CEO @ Arthrogen B.V.
CEO
2015-04-01

marlon-dijkshoorn_image

Marlon Dijkshoorn
Marlon Dijkshoorn CFO @ Arthrogen B.V.
CFO

janneke-meulenberg_image

Janneke Meulenberg
Janneke Meulenberg COO @ Arthrogen B.V.
COO
2015-05-01

Investors List

uva-ventures-holding_image

UvA Ventures Holding

UvA Ventures Holding investment in Seed Round - Arthrogen B.V.

Official Site Inspections

http://www.arthrogen.nl

  • Host name: 172.67.138.177
  • IP address: 172.67.138.177
  • Location: United States
  • Latitude: 37.751
  • Longitude: -97.822
  • Timezone: America/Chicago

Loading ...

More informations about "Arthrogen B.V."

โ˜‘๏ธArthrogen BV โ€” Consulting Organization from the โ€ฆ

Oct 11, 2024 Arthrogen BV was founded in 2005 as a joint venture between the Dubai Bone & Joint Center (DBAJ) in the United Arab Emirates and the Academic Medical Center (AMC) in โ€ฆSee details»

Arthrogen BV - UvA Ventures

Dec 17, 2019 Arthrogen BV. Arthrogen BV was founded in 2005 as a joint venture between the Dubai Bone & Joint Center (DBAJ) in the United Arab Emirates and the Academic Medical โ€ฆSee details»

Arthrogen B.V. - Crunchbase Company Profile & Funding

Contact Email [email protected] Phone Number +31.20.566.26.48 Arthrogen, an Amsterdam based biopharmaceutical company, is developing local gene therapy for โ€ฆSee details»

Arthrogen Company Profile | Management and Employees List

Arthrogen BV was founded in 2005 as a joint venture between the Dubai Bone & Joint Center (DBAJ) in the United Arab Emirates and the Academic Medical Center (AMC) in Amsterdam, โ€ฆSee details»

Company Information - RocketReach

Arthrogen BV was founded in 2005 as a joint venture between the Dubai Bone & Joint Center (DBAJ) in the United Arab Emirates and the Academic Medical Center (AMC) in Amsterdam, โ€ฆSee details»

Arthrogen Company Profile 2024: Valuation, Investors โ€ฆ

Arthrogen General Information Description. Developer of a local gene therapy intended for different indications, using viral-mediated gene transfer. The company specializes in the development of viral gene therapy vectors, in โ€ฆSee details»

Arthrogen.nl

Wij gebruiken cookies om inhoud en advertenties te personaliseren, om functies voor sociale media aan te bieden en om ons verkeer te analyseren.See details»

Arthrogen B.V. - Amsterdam Life Sciences District

Arthrogen B.V. Arthrogen is developing local gene therapy for chronic diseases, using viral mediated gene transfer. ... 0205662648 โ€“ Anouk Veneboer, Office manager: URL Company โ€ฆSee details»

Arthrogen - Products, Competitors, Financials, Employees, โ€ฆ

Arthrogen.nl. Overview & Products; People; About Arthrogen. Arthrogen is a biopharmaceutical company developing local gene therapy for different indications, using viral mediated gene โ€ฆSee details»

Arthrogen BV - Amsterdam, Netherlands - bionity.com

Apr 3, 2006 Arthrogen, an Amsterdam based biopharmaceutical company, is developing local gene therapy for inflammatory diseases, using viral mediated gene transfer. ... arthrogen.nl โ€ฆSee details»

Arthrogen B.V. - Contacts, Employees, Board Members

Arthrogen B.V. is an Amsterdam based biopharmaceutical company. Start Free Trial . Chrome ExtensionSee details»

Arthrogen - Overview, News & Similar companies | ZoomInfo.com

Arthrogen BV was founded in 2005 as a joint venture between the Dubai Bone & Joint Center (DBAJ) in the United Arab Emirates and the Academic Medical Center (AMC) in Amsterdam, โ€ฆSee details»

Arthrogen B.V. - Funding, Financials, Valuation & Investors

Nov 4, 2005 How much funding has this organization raised over time? Show . Announced Date . Transaction Name . Number of Investors . Money Raised . Lead Investors . Nov 4, 2005: โ€ฆSee details»

Arthrogen BV - Amsterdam, Pays-Bas - bionity.com

Arthrogen.nl +31205662648. Partager. Xing Linkedin Facebook X E-mail Arthrogen BV. Meibergdreef 45 1105 BA Amsterdam Pays-Bas +31205662648. arthrogen.nl. Prendre โ€ฆSee details»

Arthrogen - VentureRadar

Arthrogen, an Amsterdam based biopharmaceutical company, is developing local gene therapy for inflammatory diseases, using viral mediated gene transfer. The first target indication is in โ€ฆSee details»

Arthrogen BV - HvA Ventures Holding

Arthrogen BV. Arthrogen BV was founded in 2005 as a joint venture between the Dubai Bone & Joint Center (DBAJ) in the United Arab Emirates and the Academic Medical Center (AMC) in โ€ฆSee details»

Arthrogen BV - biobank.co.kr

Biobank dB : Arthrogen BV, development of innovative local gene therapy for patients with rheumatoid arthritis ... Meibergdreef 45. 1105 BA Amsterdam Netherlands +31-20-566-26-48 โ€ฆSee details»

Arthrogen BV - Amsterdam UMC Ventures Holding

Arthrogen BV. Arthrogen BV was founded in 2005 as a joint venture between the Dubai Bone & Joint Center (DBAJ) in the United Arab Emirates and the Academic Medical Center (AMC) in โ€ฆSee details»

MeiraGTx Netherlands BV - Drug pipelines, Patents, Clinical

Explore MeiraGTx Netherlands BV with its drug pipeline, therapeutic area, technology platform, 2 clinical trials, 4 news, Drug:ART-I02, Recombinant adeno-associated viral vector based gene โ€ฆSee details»

AAV5-CD39/CD73 (Arthrogen) - Drug Targets, Indications, Patents โ€ฆ

Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.See details»

linkstock.net © 2022. All rights reserved